Research-Peptide Articles
In-depth pieces on research-peptide mechanism, published-literature overviews, and supplier-evaluation frameworks. Cited to peer-reviewed sources where applicable.
BPC-157 is one of the most-cited regenerative-research peptides of the past decade. This article walks through what peer-reviewed publications actually describe — mechanism, where the research is strongest, where it's still preliminary, and how researchers commonly stack the compound.
Retatrutide is the third-generation GLP-family research analog that drew significant attention from the metabolic-research community after the 2023 NEJM Phase 2 publication. This article covers what the emerging literature describes, how it differs from the earlier Semaglutide and Tirzepatide analogs, and where the research is going.
CJC-1295 is available in two research forms — with the Drug Affinity Complex (DAC) and without (No DAC, also called Mod GRF 1-29). The pharmacokinetic difference between the two is dramatic and matters a lot for research-protocol design. This article covers what differs and why modern protocols predominantly use the No DAC variant.
Buying research peptides in the United States is more accessible than ever — and supplier quality varies more dramatically than ever. This article gives you a framework for evaluating any research-peptide vendor on the dimensions that actually matter: purity testing, third-party Certificate of Analysis (COA) practices, US-based shipping, sourcing transparency, and pricing fairness.